"Randomized, double blind, dose‐response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy" by Edward B Rubenstein

Article

Randomized, double blind, dose‐response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy

Cancer (1997)

Edward B Rubenstein, University of Texas MD Anderson Cancer Center
Richard J. Gralla, Albert Einstein College of Medicine
John D. Hainsworth, Sarah Cannon Research Institute
Paul J. Hesketh, Lahey Hospital & Medical Center
Thomas H. Grote
Manuel R. Modiano, University of Arizona
Ali Khojasteh, Boston University
Leonard A. Kalman, Memorial Sloan Kettering Cancer Center
Claude R. Benedict, University of Texas Health Science Center at San Antonio
William F. Hahne, Marion Merrell Dow

Link

Disciplines

Publication Date

March 15, 1997

DOI

10.1002/(SICI)1097-0142(19970315)79:6<1216::AID-CNCR22>3.0.CO;2-1

Citation Information

Edward B Rubenstein, Richard J. Gralla, John D. Hainsworth, Paul J. Hesketh, et al.. "Randomized, double blind, dose‐response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy" Cancer Vol. 79 Iss. 6 (1997) p. 1216 - 1224
Available at: http://works.bepress.com/leonard-kalman/21/